However, whilst some reports demonstrate that monoclonal anti-HMGB1 antibodies are efficacious preventing organ damage in experimental models of sepsis [155], others suggest that monoclonal antibodies are not effective in suppressing arthritic disease in vivo [175]. This evidence concerns the gene HMGB1 and Sepsis.